Skip to content
10-Q

Quarterly Report

XERIANT, INC. XERI

0001477932-25-003761

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · May 12, 2025 686.9M sh
Stockholders Equity Q3 2025 · Mar 31, 2025 −$5.71M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$5.75M
Current Liabilities Q3 2025 · Mar 31, 2025 $8.66M
Current Liabilities Q3 2025 · Jun 30, 2024 $9.33M
Total Liabilities Q3 2025 · Mar 31, 2025 $8.66M
Total Liabilities Q3 2025 · Jun 30, 2024 $9.33M
Current Assets Q3 2025 · Mar 31, 2025 $61.92K
Current Assets Q3 2025 · Jun 30, 2024 $664.21K
Total Assets Q3 2025 · Mar 31, 2025 $73.17K
Total Assets Q3 2025 · Jun 30, 2024 $713.01K
Shares Diluted Q3 2025 · Mar 31, 2024 449.27M sh
Shares Diluted Q3 2025 · Mar 31, 2024 422.07M sh
Operating Cash Flow Q3 2025 · Mar 31, 2024 −$1.06M
Eps Diluted Q3 2025 · Mar 31, 2024 $0.00
Eps Diluted Q3 2025 · Mar 31, 2024 $0.00
Rd Expense Q3 2025 · Mar 31, 2024 $67.52K
Rd Expense Q3 2025 · Mar 31, 2024 $147.26K
Net Income restated Q3 2025 · Mar 31, 2024 −$376.33K
Net Income restated Q3 2025 · Mar 31, 2024 −$1.91M
Operating Income Q3 2025 · Mar 31, 2024 −$352.96K
Operating Income Q3 2025 · Mar 31, 2024 −$1.01M